Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/20719
Title: Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey.
Authors: Pironi, Loris;Steiger, Ezra;Brandt, Chrisoffer;Joly, Francisca;Wanten, Geert;Chambrier, Cecile;Aimasso, Umberto;Sasdelli, Anna Simona;Zeraschi, Sarah;Kelly, Darlene;Szczepanek, Kinga;Jukes, Amelia;Di Caro, Simona;Theilla, Miriam;Kunecki, Marek;Daniels, Joanne;Serlie, Mireille;Poullenot, Florian;Wu, Jian;Cooper, Sheldon C;Rasmussen, Henrik H;Compher, Charlene;Seguy, David;Crivelli, Adriana;Pagano, Maria C;Hughes, Sarah-Jane;Guglielmi, Francesco W;Kozjek, Nada Rotovnik;Schneider, Stéphane M;Gillanders, Lyn;Ellegard, Lars;Thibault, Ronan;Matras, Przemysław;Zmarzly, Anna;Matysiak, Konrad;Van Gossum, Andrè;Forbes, Alastair;Wyer, Nicola;Taus, Marina;Virgili, Nuria M;O'Callaghan, Margie;Chapman, Brooke;Osland, Emma;Cuerda, Cristina;Sahin, Peter;Jones, Lynn;Won Lee, Andre Dong;Masconale, Luisa;Orlandoni, Paolo;Izbéki, Ferenc;Spaggiari, Corrado;Bueno, Marta;Doitchinova-Simeonova, Maryana;Garde, Carmen;Serralde-Zúñiga, Aurora E;Olveira, Gabriel;Krznaric, Zeljko;Czako, Laszlo;Kekstas, Gintautas;Sanz-Paris, Alejandro;Jáuregui, Estrella Petrina;Murillo, Ana Zugasti;Schafer, Eszter;Arends, Jann;Suárez-Llanos, José P;Lal, Simon
Affiliation: St. Orsola University Hospital, Bologna, Italy.
Flinders Medical Centre, Adelaide, Australia
Cleveland Clinic Foundation, Cleveland, OH, USA
Royal Prince Alfred Hospital, Sydney, Australia
Royal Brisbane and Women's Hospital, Herston, Australia
Rigshospitalet, Copenhagen, Denmark
Beaujon Hospital, Clichy, France
Radboud University Medical Center, Nijmegen, the Netherlands
Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Lyon, France
Città della Salute e della Scienza, Torino, Italy
St. Orsola University Hospital, Bologna, Italy
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Mayo Clinic College of Medicine, Rochester, MN, USA
Stanley Dudrick's Memorial Hospital, Skawina, Poland
University Hospital of Wales, Cardiff, United Kingdom
University College Hospital, London, United Kingdom
Rabin Medical Center, Petach Tikva, Israel
M. Pirogow Hospital, Lodz, Poland
Nottingham University Hospital NHS Trust, Nottingham, United Kingdom
Academic Medical Center, Amsterdam, the Netherlands
CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac, France
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Center for Nutrition and Bowel Disease, Aalborg University Hospital, Aalborg, Denmark
Hospital of the University of Pennsylvania, Philadelphia, PA, USA
CHRU de Lille, Lille, France
Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina
Federico II University, Napoli, Italy
Regional Intestinal Failure Service, Belfast Health and Social Care Trust, Northern Ireland, United Kingdom
San Nicola Pellegrino Hospital, Trani, Italy
Institute of Oncology, Ljubljana, Slovenia
CHU Archet, Nice, France
Auckland City Hospital, Auckland, New Zealand
Sahlgrenska University Hospital, Gothenburg, Sweden
Nutrition unit, CHU Rennes, Nutrition Metabolisms and Cancer Institute, NuMeCan, INRA, INSERM, Université Rennes, Rennes, France
Medical University of Lublin, Lublin, Poland
J. Gromkowski City Hospital, Wroclaw, Poland
H.Święcicki University Hospital, Poznań, Poland
Hôpital Erasme, Brussels, Belgium
Norfolk and Norwich University Hospital, Norwich, United Kingdom
University Hospital, Coventry, United Kingdom
Ospedali Riuniti, Ancona, Italy
Hospital Universitari de Bellvitge, Barcelona, Spain
Austin Health, Heidelberg, Victoria, Australia
Hospital General Universitario Gregorio Marañon, Madrid, Spain
St. Imre Hospital, Budapest, Hungary
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
ULSS 22 Ospedale Orlandi, Bussolengo, Italy
INRCA - IRCCS, Ancona, Italy
Szent György Teaching Hospital of County Fejér, Székesfehérvár, Hungary
AUSL di Parma, Parma, Italy
Hospital Universitario Arnau de Vilanova, Lleida, Spain
Bulgarian Executive Agency of Transplantation, Sofia, Bulgaria
Hospital Universitario Donostia, San Sebastian, Spain
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico
IBIMA, Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain
University Hospital Centre Zagreb, Zagreb, Croatia
University of Szeged, Szeged, Hungary
Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
Miguel Servet Hospital, Zaragoza, Spain
Complejo Hospitalario de Navarra, Pamplona, Spain
Hospital Virgen del Camino, Pamplona, Spain
Magyar Honvedseg Egészségügyi Központ (MHEK), Budapest, Hungary
Tumor Biology Center, Freiburg, Germany
Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
Salford Royal NHS Foundation Trust, Salford, United Kingdom
Issue Date: 25-Mar-2019
EDate: 2019
Citation: Clinical nutrition (Edinburgh, Scotland) 2019; online first: 25 March
Abstract: The safety and effectiveness of a home parenteral nutrition (HPN) program depends both on the expertise and the management approach of the HPN center. We aimed to evaluate both the approaches of different international HPN-centers in their provision of HPN and the types of intravenous supplementation (IVS)-admixtures prescribed to patients with chronic intestinal failure (CIF). In March 2015, 65 centers from 22 countries enrolled 3239 patients (benign disease 90.1%, malignant disease 9.9%), recording the patient, CIF and HPN characteristics in a structured database. The HPN-provider was categorized as health care system local pharmacy (LP) or independent home care company (HCC). The IVS-admixture was categorized as fluids and electrolytes alone (FE) or parenteral nutrition, either commercially premixed (PA) or customized to the individual patient (CA), alone or plus extra FE (PAFE or CAFE). Doctors of HPN centers were responsible for the IVS prescriptions. HCC (66%) was the most common HPN provider, with no difference noted between benign-CIF and malignant-CIF. LP was the main modality in 11 countries; HCC prevailed in 4 European countries: Israel, USA, South America and Oceania (p < 0.001). IVS-admixture comprised: FE 10%, PA 17%, PAFE 17%, CA 38%, CAFE 18%. PA and PAFE prevailed in malignant-CIF while CA and CAFE use was greater in benign-CIF (p < 0.001). PA + PAFE prevailed in those countries where LP was the main HPN-provider and CA + CAFE prevailed where the main HPN-provider was HCC (p < 0.001). This is the first study to demonstrate that HPN provision and the IVS-admixture differ greatly among countries, among HPN centers and between benign-CIF and cancer-CIF. As both HPN provider and IVS-admixture types may play a role in the safety and effectiveness of HPN therapy, criteria to homogenize HPN programs are needed so that patients can have equal access to optimal CIF care.
URI: http://ahro.austin.org.au/austinjspui/handle/1/20719
DOI: 10.1016/j.clnu.2019.03.010
PubMed URL: 30992207
Type: Journal Article
Subjects: Cancer
Home parenteral nutrition
Intestinal failure
Intravenous supplementation
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.